Ildefonso Rodriguez-Rivera
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- RNA and protein synthesis mechanisms 1
- Protein Degradation and Inhibitors 1
-
- Lymphoma Diagnosis and Treatment 2
- Co-authors
- Sangeetha Palakurthi (1 shared paper)Ariela Noy (3 shared papers)Matthew J. Matasar (3 shared papers)Yan Moore (1 shared paper)Tinghui Wu (1 shared paper)William Senapedis (1 shared paper)Colette Owens (3 shared papers)Steven M. Horwitz (3 shared papers)
- Journals
- Blood (3 papers)Journal of Clinical Oncology (2 papers)Nature Medicine (1 paper)Clinical Cancer Research (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesSpainGermany
In The Last Decade
Ildefonso Rodriguez-Rivera
6 papers receiving 23 citations
Peers
Comparison fields: 5 of 19
- Cancer Research 8
- Hepatology 2
- Immunology 5
- Pathology and Forensic Medicine 4
- Genetics 2
Countries citing papers authored by Ildefonso Rodriguez-Rivera
This map shows the geographic impact of Ildefonso Rodriguez-Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ildefonso Rodriguez-Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ildefonso Rodriguez-Rivera more than expected).
Fields of papers citing papers by Ildefonso Rodriguez-Rivera
This network shows the impact of papers produced by Ildefonso Rodriguez-Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ildefonso Rodriguez-Rivera. The network helps show where Ildefonso Rodriguez-Rivera may publish in the future.
Co-authors
The 25 scholars most cited alongside Ildefonso Rodriguez-Rivera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2025 | 5 | |
| 3 | 2021 | 5 | |
| 4 | 2020 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2014 | 1 | |
| 7 | 2026 | 0 | |
| 8 | 2025 | 0 | |
| 9 | 2025 | 0 |
About Ildefonso Rodriguez-Rivera
Ildefonso Rodriguez-Rivera is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 9 papers that have together received 23 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Colorectal Cancer Treatments and Studies (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), RNA and protein synthesis mechanisms (1 paper), Protein Degradation and Inhibitors (1 paper), Biochemical Acid Research Studies (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Cancer Research (8 citations), Hepatology (2 citations), Immunology (5 citations), Pathology and Forensic Medicine (4 citations) and Genetics (2 citations). Ildefonso Rodriguez-Rivera has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Sangeetha Palakurthi, Ariela Noy, Matthew J. Matasar, Yan Moore, Tinghui Wu, William Senapedis, Colette Owens, Steven M. Horwitz, David J. Straus and Gilbert Y. Wong. Their work appears in journals such as Blood, Journal of Clinical Oncology, Nature Medicine, Clinical Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.